InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
ODN 2006 (ODN 7909) | Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implica... | 2021 | Blood Cancer J. | Lu P. et al. | DOI: 10.1038/s41408-021-00429-z |
Hygromycin B Gold | Naked mole rat TRF1 safeguards glycolytic capacity and telomere replication u... | 2021 | Sci Adv. | Augereau A. et al. | DOI: 10.1126/sciadv.abe0174 |
Puromycin | Naked mole rat TRF1 safeguards glycolytic capacity and telomere replication u... | 2021 | Sci Adv. | Augereau A. et al. | DOI: 10.1126/sciadv.abe0174 |
Primocin® | Naked mole rat TRF1 safeguards glycolytic capacity and telomere replication u... | 2021 | Sci Adv. | Augereau A. et al. | DOI: 10.1126/sciadv.abe0174 |
PMA - Phorbol myristate acetate | LACC1 deficiency links juvenile arthritis with autophagy and metabolism in ma... | 2021 | J Exp Med. | Omarjee O. et al. | DOI: 10.1084/jem.20201006 |
CL097 | Low immune activation in early pregnancy is associated with preterm but not s... | 2021 | Clin Infect Dis. | Mdletshe N. et al. | DOI: 10.1093/cid/ciab151 |
CFA | IL10- and IL35-Secreting MutuDC Lines Act in Cooperation to Inhibit Memory T ... | 2021 | Front. Immunol. | Koga M.M. et al. | DOI: 10.3389/fimmu.2021.607315 |
Ruxolitinib | Transient prenatal ruxolitinib treatment suppresses astrogenesis during devel... | 2021 | Sci Rep. | Lee H.C. et al. | DOI: 10.1038/s41598-021-83222-z |
Plasmocin® - Mycoplasma Elimination Reagent | AraC-FdUMP[10] (CF10) is a next generation fluoropyrimidine with potent antit... | 2021 | Mol Cancer Res. | Haber A.O. et al. | DOI: 10.1158/1541-7786.MCR-20-0985 |
Plasmocin® - Mycoplasma Elimination Reagent | PLA2R1 promotes DNA damage and inhibits spontaneous tumor formation during ag... | 2021 | Cell Death Dis. | Huna A. et al. | DOI: 10.1038/s41419-021-03468-3 |
LPS-EB (LPS from E. coli O111:B4) | IL-22 promotes the formation of a MUC17 glycocalyx barrier in the postnatal s... | 2021 | Cell Rep. | Layunta E. et al. | DOI: 10.1016/j.celrep.2021.108757 |
IL-2 & IL-15 Reporter HEK 293 Cells | Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 ... | 2020 | Antimicrob Agents Chemother. | Sorensen E.S. et al. | DOI: 10.1128/AAC.00888-20 |
IL-2 & IL-15 Reporter HEK 293 Cells | Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor t... | 2020 | Oncoimmunology | Kujawski M. et al. | DOI: 10.1080/2162402X.2020.1724052 |
LPS-EK (LPS from E. coli K12) | Identification of anti‐inflammatory vesicle‐like nanoparticles in honey. | 2021 | J. Extracell. Vesicles | Chen X. et al. | DOI: 10.1002/jev2.12069 |
Plasmocin® - Mycoplasma Elimination Reagent | NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy | 2021 | Cancers (Basel). | Sanghvi V.R. et al. | DOI: 10.3390/cancers13040639 |
pFUSE-hIgG1-Fc | Targeting galectin-3 with a high-affinity antibody for inhibition of high-gra... | 2021 | Sci Rep. | Stasenko M. et al. | DOI: 10.1038/s41598-021-82686-3 |
Quil-A® adjuvant | Analysis of Immune Gene Expression in Seabass (Lates calcarifer) Immunized wi... | 2021 | Indian J. Anim. Res. | Sivasankar P et al | DOI: 10.18805/IJAR.B-3813 |
Zeocin® | Identification, heterologous production and bioactivity of lentinulin A and d... | 2021 | Sci Rep. | Matabaro E. et al. | DOI: 10.1038/s41598-021-83106-2 |
Primocin® | Chromosome-scale genome assembly of the sea louse Caligus rogercresseyi by SM... | 2021 | Sci Data. | Gallardo-Escárate C. et al. | DOI: 10.1038/s41597-021-00842-w |
LPS-EK (LPS from E. coli K12) | Hypercapnia selectively modulates LPS-induced changes in innate immune and DN... | 2021 | Interface Focus | Casalino-Matsuda S.M. et al. | DOI: 10.1098/rsfs.2020.0039 |